1. Home
  2. EDIT vs NRDY Comparison

EDIT vs NRDY Comparison

Compare EDIT & NRDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDIT
  • NRDY
  • Stock Information
  • Founded
  • EDIT 2013
  • NRDY 2007
  • Country
  • EDIT United States
  • NRDY United States
  • Employees
  • EDIT N/A
  • NRDY N/A
  • Industry
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • NRDY Computer Software: Prepackaged Software
  • Sector
  • EDIT Health Care
  • NRDY Technology
  • Exchange
  • EDIT Nasdaq
  • NRDY Nasdaq
  • Market Cap
  • EDIT 179.1M
  • NRDY 206.0M
  • IPO Year
  • EDIT 2016
  • NRDY N/A
  • Fundamental
  • Price
  • EDIT $2.88
  • NRDY $1.60
  • Analyst Decision
  • EDIT Buy
  • NRDY Hold
  • Analyst Count
  • EDIT 12
  • NRDY 8
  • Target Price
  • EDIT $6.20
  • NRDY $1.90
  • AVG Volume (30 Days)
  • EDIT 3.5M
  • NRDY 586.3K
  • Earning Date
  • EDIT 08-06-2025
  • NRDY 08-07-2025
  • Dividend Yield
  • EDIT N/A
  • NRDY N/A
  • EPS Growth
  • EDIT N/A
  • NRDY N/A
  • EPS
  • EDIT N/A
  • NRDY N/A
  • Revenue
  • EDIT $35,837,000.00
  • NRDY $184,099,000.00
  • Revenue This Year
  • EDIT N/A
  • NRDY $4.60
  • Revenue Next Year
  • EDIT N/A
  • NRDY $9.97
  • P/E Ratio
  • EDIT N/A
  • NRDY N/A
  • Revenue Growth
  • EDIT N/A
  • NRDY N/A
  • 52 Week Low
  • EDIT $0.91
  • NRDY $0.73
  • 52 Week High
  • EDIT $6.05
  • NRDY $2.18
  • Technical
  • Relative Strength Index (RSI)
  • EDIT 74.64
  • NRDY 49.77
  • Support Level
  • EDIT $2.48
  • NRDY $1.60
  • Resistance Level
  • EDIT $3.24
  • NRDY $1.69
  • Average True Range (ATR)
  • EDIT 0.25
  • NRDY 0.07
  • MACD
  • EDIT 0.07
  • NRDY 0.00
  • Stochastic Oscillator
  • EDIT 84.84
  • NRDY 62.50

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

About NRDY Nerdy Inc.

Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.

Share on Social Networks: